C5a stimulates the proliferation of breast cancer cells via Akt-dependent RGC-32 gene activation

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2817-2823

  Lu, Yi ^a   Hu, Xiao Bo ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Central South University   (China)

Author keywords

Akt; Breast cancer; C5a; Proliferation; Response gene to complement 32

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; C3 PROTEIN, HUMAN; C5AR1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; COMPLEMENT COMPONENT C3; MUSCLE PROTEIN; NERVE PROTEIN; RGC32 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; RGC 32 GENE; TUMOR PROMOTION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST TUMOR; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COMPLEMENT C3; COMPLEMENT C5A; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ANAPHYLATOXIN C5A; TRANSCRIPTIONAL ACTIVATION;

EID: 84914670355     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3489     Document Type: Article

References (37)

1. Tong HH, Lambert G, Li YX, et al: Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice. PloS One 9: e95160, 2014.
2. Courtois A, Berthou C, Guezennec J, Boisset C and Bordron A: Exopolysaccharides isolated from hydrothermal vent bacteria can modulate the complement system. PloS One 9: e94965, 2014.
3. Wende E, Laudeley R, Bleich A, et al: The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice. PloS One 8: e62257, 2013.
4. Elvington M, Blichmann P, Qiao F, et al: A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis. Clin Exp Immunol: 500-508, 2014.
5. Hundgeburth LC, Wunsch M, Rovituso D, et al: The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response. Clin Immunol 146: 155-164, 2013.
6. Laudisi F, Spreafico R, Evrard M, et al: Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J Immunol 191: 1006-1010, 2013.
7. Ma R, Cui Z, Hu SY, et al: The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease. PloS One 9: e91250, 2014.
8. Osthoff M, Brown KD, Kong DC, Daniell M and Eisen DP: Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa. Mol Vis 20: 38-45, 2014.
9. Cravedi P, Leventhal J, Lakhani P, Ward SC, Donovan MJ and Heeger PS: Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. Am J Transplant 13: 2530-2539, 2013.
10. van der Touw W, Cravedi P, Kwan WH, Paz-Artal E, Merad M and Heeger PS: Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol 190: 5921-5925, 2013.
11. Lara-Astiaso D, Izarra A, Estrada JC, et al: Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal. Springerplus 1: 63, 2012. doi: 10.1186/2193-1801-1-63.
12. Kanmura S, Uto H, Sato Y, et al: The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol 45: 459-467, 2010.
13. Habermann JK, Roblick UJ, Luke BT, et al: Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. Gastroenterology 131: 1020-1029, 2006.
14. Stecker JR, Savage AA, Bruno JG, Garcia DM and Koke JR: Dynamics and visualization of MCF7 adenocarcinoma cell death by aptamer-C1q-mediated membrane attack. Nucleic Acid Ther 22: 275-282, 2012.
15. Baig NA, Taylor RP, Lindorfer MA, et al: Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement. Leuk Lymphoma 53: 2218-2227, 2012.
16. Nitta H, Wada Y, Kawano Y, et al: Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88). Clin Cancer Res 19: 2004-2013, 2013.
17. Corrales L, Ajona D, Rafail S, et al: Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol 189: 4674-4683, 2012.
18. Fosbrink M, Cudrici C, Tegla CA, et al: Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp Mol Pathol 86: 87-94, 2009.
19. Vlaicu SI, Cudrici C, Ito T, et al: Role of response gene to complement 32 in diseases. Arch Immunol Ther Exp 56: 115-122, 2008.
20. Badea TC, Niculescu FI, Soane L, Shin ML and Rus H: Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J Biol Chem 273: 26977-26981, 1998.
21. Vlaicu SI, Tegla CA, Cudrici CD, et al: Epigenetic modifications induced by RGC-32 in colon cancer. Exp Mol Pathol 88: 67-76, 2010.
22. Li F, Luo Z, Huang W, et al: Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells. J Biol Chem 282: 10133-10137, 2007.
23. Zhu L, Qin H, Li PY, et al: Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3. J Exp Clin Cancer Res 31: e29, 2012.
24. Yunus MA, Chung LM, Chaudhry Y, Bailey D and Goodfellow I: Development of an optimized RNA-based murine norovirus reverse genetics system. J Virol Methods 169: 112-118, 2010.
25. Li M, Han S, Zhang G, Wang Y and Ji Z: Antiproliferative activity and apoptosis-inducing mechanism of L-securinine on human breast cancer MCF-7 cells. Pharmazie 69: 217-223, 2014.
26. Gong S, Tao Z, Liu X and Gan L: An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18. Biomed Rep 2: 85-88, 2014.
27. Qiu W, Zhang Y, Liu X, et al: Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation. J Pathol 226: 619-632, 2012.
28. Tang H, Amara U, Tang D, Barnes MA, McDonald C and Nagy LE: Synergistic interaction between C5a and NOD2 signaling in the regulation of chemokine expression in RAW 264.7 macrophages. Adv Biosci Biotechnol 4: 30-37, 2013.
29. Curci C, Castellano G, Stasi A, et al: Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant 29: 799-808, 2014.
30. Byler S, Goldgar S, Heerboth S, et al: Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res 34: 1071-1077, 2014.
31. Faria JA, Correa NC, de Andrade C, et al: SET domain-containing protein 4 (SETD4) is a newly identified cytosolic and nuclear lysine methyltransferase involved in breast cancer cell proliferation. J Cancer Sci Ther 5: 58-65, 2013.
32. Pei R, Wang P, Zhou Y, et al: Association of BRCA1 K1183R polymorphism with survival in BRCA1/2-negative Chinese familial breast cancer. Clin Lab 60: 47-53, 2014.
33. Unnewehr H, Rittirsch D, Sarma JV, et al: Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol 190: 4215-4225, 2013.
34. Liu L, Zhang Y, Duan X, et al: C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy. J Clin Immunol 34: 224-232, 2014.
35. Müller MC, Stroo I, Wouters D, et al: The effect of C1-inhibitor in a murine model of transfusion-related acute lung injury. Vox Sang 107: 71-75, 2014.
36. Qin L, Ren Y, Chen AM, et al: Peroxisome proliferator-activated receptor γ ligands in hibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway. Mol Med Rep 10: 276-282, 2014.
37. Singel SM, Cornelius C, Zaganjor E, et al: KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triplenegative breast cancer. Neoplasia 16: 247-256, 2014.